U.S. markets ended Wednesday's session mixed as traders digested mixed data on the economic front. Albert Fried Managing Director Ben Willis says there was confusion in the markets and traders are sitting on the sidelines waiting for Friday's January jobs report. Willis says one bright spot were shares in pharmaceutical stocks. Willis says the VIX, which is a widely tracked measure of market sentiment, suggest there is more volatility ahead. 'More volatility,' Willis says, means the market is in 'correction mode.' TheStreet's Ruben Ramirez reports from the NYSE.

If you liked this article you might like

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

The Jury Is Still Out on Merck

The Jury Is Still Out on Merck

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Volatility Is Still in Charge: Cramer's 'Mad Money' Recap (Friday, 2/9/18)

Taking Merck's Temperature

Taking Merck's Temperature

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here